Skip to main content
. Author manuscript; available in PMC: 2015 Nov 17.
Published in final edited form as: Eur Respir J. 2009 Aug;34(2):489–506. doi: 10.1183/09031936.00042409

FIGURE 6.

FIGURE 6

Kaplan–Meier analysis of overall survival in the Eastern Cooperative Oncology Group validation cohort (n=96). These patients had advanced nonsmall cell lung cancer and had been treated first line with erlotinib alone. red; poor event-free fraction; green: good event-free fraction; ------: 95% confidence intervals; |: censored patients. Reproduced from [181], with permission from the publisher.